Strategies That Facilitate Extraction-Free SARS-CoV-2 Nucleic Acid Amplification Tests
Overview
Authors
Affiliations
The COVID-19 pandemic has resulted in an unprecedented global demand for in vitro diagnostic reagents. Supply shortages and hoarding have impacted testing capacity which has led to inefficient COVID-19 case identification and transmission control, predominantly in developing countries. Traditionally, RNA extraction is a prerequisite for conducting SARS-CoV-2 nucleic acid amplification tests (NAAT); however, simplified methods of sample processing have been successful at bypassing typical nucleic acid extraction steps, enabling extraction-free SARS-CoV-2 NAAT workflows. These methods involve chemical and physical approaches that are inexpensive and easily accessible alternatives to overcome extraction kit supply shortages, while offering acceptable test performance. Here we provide an overview of three main sample preparation strategies that have been shown to facilitate extraction-free SARS-CoV-2 NAATs.
Kundrod K, Natoli M, Smith C, Coole J, Chang M, Novak E Anal Bioanal Chem. 2025; .
PMID: 39920386 DOI: 10.1007/s00216-025-05765-8.
Yalley A, Ahiatrogah S, Moro I, Gmagna P, Yankson I, Kafintu-Kwashie A Diseases. 2024; 12(9).
PMID: 39329867 PMC: 11430816. DOI: 10.3390/diseases12090198.
FlashPCR: Revolutionising qPCR by Accelerating Amplification through Low ∆T Protocols.
Bustin S, Kirvell S, Nolan T, Shipley G Int J Mol Sci. 2024; 25(5).
PMID: 38474020 PMC: 10932470. DOI: 10.3390/ijms25052773.
de Souza L, Silva I, Celis-Silva G, Raddatz B, Imamura L, Kim E Exp Biol Med (Maywood). 2023; 248(19):1671-1683.
PMID: 38088106 PMC: 10723028. DOI: 10.1177/15353702231215815.
Digital Microfluidic Multiplex RT-qPCR for SARS-CoV-2 Detection and Variants Discrimination.
Ho K, Ding J, Fan J, Tsui W, Bai J, Fan S Micromachines (Basel). 2023; 14(8).
PMID: 37630161 PMC: 10456927. DOI: 10.3390/mi14081627.